120 related articles for article (PubMed ID: 35059640)
1. A functional artificial neural network for noninvasive pretreatment evaluation of glioblastoma patients.
Zander E; Ardeleanu A; Singleton R; Bede B; Wu Y; Zheng S
Neurooncol Adv; 2022; 4(1):vdab167. PubMed ID: 35059640
[TBL] [Abstract][Full Text] [Related]
2. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Zheng S; Wu Y; Li Z
Radiother Oncol; 2021 Jan; 154():36-44. PubMed ID: 32918970
[TBL] [Abstract][Full Text] [Related]
3. AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis.
Cheung EYW; Wu RWK; Li ASM; Chu ESM
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894430
[TBL] [Abstract][Full Text] [Related]
4. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
5. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
[TBL] [Abstract][Full Text] [Related]
7. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Zheng S; Tao W
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804433
[TBL] [Abstract][Full Text] [Related]
9. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
Front Oncol; 2020; 10():590352. PubMed ID: 33392085
[TBL] [Abstract][Full Text] [Related]
10. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
[TBL] [Abstract][Full Text] [Related]
12. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
Chaddad A; Sabri S; Niazi T; Abdulkarim B
Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
[TBL] [Abstract][Full Text] [Related]
13. Is age an additional factor in the treatment of elderly patients with glioblastoma? A new stratification model: an Italian Multicenter Study.
Ius T; Somma T; Altieri R; Angileri FF; Barbagallo GM; Cappabianca P; Certo F; Cofano F; D'Elia A; Della Pepa GM; Esposito V; Fontanella MM; Germanò A; Garbossa D; Isola M; La Rocca G; Maiuri F; Olivi A; Panciani PP; Pignotti F; Skrap M; Spena G; Sabatino G
Neurosurg Focus; 2020 Oct; 49(4):E13. PubMed ID: 33002864
[TBL] [Abstract][Full Text] [Related]
14. Development of an Immune-Related Prognostic Index Associated With Glioblastoma.
Jiang Z; Shi Y; Zhao W; Zhang Y; Xie Y; Zhang B; Tan G; Wang Z
Front Neurol; 2021; 12():610797. PubMed ID: 34093386
[No Abstract] [Full Text] [Related]
15. Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
Zheng S; Li Z
Aging (Albany NY); 2020 Sep; 12(17):17380-17392. PubMed ID: 32931454
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of
Wang H; Wang X; Xu L; Zhang J; Cao H
Front Oncol; 2021; 11():551160. PubMed ID: 33959491
[No Abstract] [Full Text] [Related]
17. Deep learning identified glioblastoma subtypes based on internal genomic expression ranks.
Mao XG; Xue XY; Wang L; Lin W; Zhang X
BMC Cancer; 2022 Jan; 22(1):86. PubMed ID: 35057766
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
Lehrer S; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
